NZ184161A - Pharmaceutical and veterinary compositions with certain methylamines as active ingredients - Google Patents

Pharmaceutical and veterinary compositions with certain methylamines as active ingredients

Info

Publication number
NZ184161A
NZ184161A NZ184161A NZ18416177A NZ184161A NZ 184161 A NZ184161 A NZ 184161A NZ 184161 A NZ184161 A NZ 184161A NZ 18416177 A NZ18416177 A NZ 18416177A NZ 184161 A NZ184161 A NZ 184161A
Authority
NZ
New Zealand
Prior art keywords
methylamines
pharmaceutical
certain
active ingredients
veterinary compositions
Prior art date
Application number
NZ184161A
Inventor
M Broll
P Eymard
C Pigerol
J-C Vernieres
Original Assignee
Labaz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labaz filed Critical Labaz
Priority to NZ190687A priority Critical patent/NZ190687A/en
Priority to NZ190688A priority patent/NZ190688A/en
Publication of NZ184161A publication Critical patent/NZ184161A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/08—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ184161A 1976-06-03 1977-05-20 Pharmaceutical and veterinary compositions with certain methylamines as active ingredients NZ184161A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
NZ190687A NZ190687A (en) 1976-06-03 1977-05-20 Methylamine derivatives and pharmaceutically acceptable acid addition salts
NZ190688A NZ190688A (en) 1976-06-03 1977-05-20 Methylamine derivatives and pharmaceutically acceptable acid addition salts

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE842528 1976-06-03

Publications (1)

Publication Number Publication Date
NZ184161A true NZ184161A (en) 1980-10-08

Family

ID=3861370

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ184161A NZ184161A (en) 1976-06-03 1977-05-20 Pharmaceutical and veterinary compositions with certain methylamines as active ingredients

Country Status (17)

Country Link
JP (1) JPS6039261B2 (en)
AR (4) AR213646A1 (en)
AT (1) AT352088B (en)
AU (1) AU511705B2 (en)
DK (1) DK146063C (en)
ES (2) ES459466A1 (en)
FI (1) FI63015C (en)
FR (2) FR2374901A1 (en)
GR (1) GR61148B (en)
MX (1) MX4778E (en)
NL (1) NL7706052A (en)
NO (1) NO145337C (en)
NZ (1) NZ184161A (en)
PT (1) PT66623B (en)
SE (2) SE452317B (en)
YU (1) YU129577A (en)
ZA (1) ZA773151B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES437790A1 (en) * 1974-05-20 1977-05-16 Labaz Therapeutic compositions containing methylamine derivatives or their salts
BE842528R (en) * 1976-06-03 1976-12-03 METHYLAMINE ACTIVE DERIVATIVES, THERAPEUTIC COMPOSITIONS CONTAINING THEM AND THE PROCESSES FOR THE PREPARATION OF THESE DERIVATIVES AND COMPOSITIONS

Also Published As

Publication number Publication date
GR61148B (en) 1978-09-27
YU129577A (en) 1983-01-21
FI771780A (en) 1977-12-04
SE7706448L (en) 1977-12-04
NO145337B (en) 1981-11-23
AU2556177A (en) 1978-11-30
NL7706052A (en) 1977-12-06
DK146063B (en) 1983-06-20
AR215175A1 (en) 1979-09-14
FR2372795B1 (en) 1983-08-12
DK146063C (en) 1983-11-14
FR2374901A1 (en) 1978-07-21
JPS52148006A (en) 1977-12-08
ES470379A1 (en) 1979-10-16
SE8206445D0 (en) 1982-11-12
MX4778E (en) 1982-09-15
FI63015C (en) 1983-04-11
FR2374901B1 (en) 1981-04-17
SE8206445L (en) 1982-11-12
SE452763B (en) 1987-12-14
AT352088B (en) 1979-08-27
AR215053A1 (en) 1979-08-31
AU511705B2 (en) 1980-09-04
FI63015B (en) 1982-12-31
NO145337C (en) 1982-03-03
PT66623B (en) 1978-11-07
NO771941L (en) 1977-12-06
SE452317B (en) 1987-11-23
ZA773151B (en) 1978-04-26
ATA395877A (en) 1979-02-15
JPS6039261B2 (en) 1985-09-05
DK244677A (en) 1977-12-04
ES459466A1 (en) 1978-08-16
AR213646A1 (en) 1979-02-28
FR2372795A1 (en) 1978-06-30
AR215052A1 (en) 1979-08-31
PT66623A (en) 1977-07-01

Similar Documents

Publication Publication Date Title
NZ188626A (en) Acylanilides and pharmaceutical and veterinary compositions
JPS52136172A (en) Polypeptide* its preparation and medical and veterinary compositions having rulibeline synergistic effect
IL53063A (en) Phenoxy-amino-propanols,processes for their preparation and pharmaceutical compositions comprising them
KE3224A (en) Antibacterial pharmaceutical and feedstuff compositions
NZ188173A (en) 7-arylmalonamido-7 a-methoxy-3-(optionally alkylated-thiadiazol-2-yl) thiomethyl-1-oxadethiacephalosporins preparation and pharmaceutical and veterinary compositions
NZ183551A (en) Aminochromanols and pharmaceutical compositions containingthem
NZ185358A (en) Spiro-hydantoins and pharmaceutical compositions
JPS5386038A (en) Pharmaceutical composition for animal and application
NZ184428A (en) N-acyl-l-alanyl-aminoacyl-amides untermediates and pharmaceutical compositions
NZ184263A (en) N-(amino-alkyl-amino)-benzamides and pharmaceutical compositions
NZ186119A (en) 7-alkoxycarbonyl-6-alkyl/halo-17-hydoxy-3-oxo-17 -pregn-4-ene-21-carboxylic acid derivatives and pharmaceutical compositions
NZ184912A (en) 2-phenylamino-imidazolines and pharmaceutical compositions
NZ184187A (en) W-nor-aromatic-13,14-dehydro-prostaglandins pharmaceutical and veterinary compositions intermediates
JPS5346972A (en) Polypeptide* its preparation and pharmaceutical* veterinary composition having rulibeline antagonism
GB2058562B (en) Pharmaceutical compositions containing paracetamol and ascorbic acid
JPS5362834A (en) Pharmaceutical composition and use thereof
IL52615A (en) 1-aza-prostaglandin analogues,their preparation and pharmaceutical compositions containing them
NZ183549A (en) Amidinopencillanoyloxy-alkyl-amoxycillinates and pharmaceutical compositions
IL52638A (en) Clivanic acid derivatives,their preparation and pharmaceutical compositions containing them
NZ185643A (en) Substituted 0-phenylene diamine derivatives and pharmaceutical and veterinary compositions
NZ186059A (en) 3-sulphamoyl-5-pyrrolylal-kylbenzoic acid derivatives and pharmaceutical compositions
IL51866A0 (en) Pharmaceutical veterinary and cosmetic compositions containing fluoroacyltesorcins
JPS5344565A (en) Novel n*nndimethylloopyrazolyllcarbamate* its preparation and incecticidal composition containing same as active ingredient
NZ184161A (en) Pharmaceutical and veterinary compositions with certain methylamines as active ingredients
NZ183756A (en) Bis-penicillanoyloxy-alkanes and pharmaceutical compositions